Search Results - Farhad Ravandi

Refine Results
  1. 1
    How I treat Philadelphia chromosome–positive acute lymphoblastic leukemia

    How I treat Philadelphia chromosome–positive acute lymphoblastic leukemia by Farhad Ravandi

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

    Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia by Farhad Ravandi, Partow Kebriaei

    Published 2009
    Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    Immune defects in patients with chronic lymphocytic leukemia

    Immune defects in patients with chronic lymphocytic leukemia by Farhad Ravandi, Susan O’Brien

    Published 2005
    Get full text
    Revisão
    Save to List
    Saved in:
  4. 4
    How close are we to incorporating measurable residual disease into clinical practice for acute myeloid leukemia?

    How close are we to incorporating measurable residual disease into clinical practice for acute myeloid leukemia? by Nicholas J. Short, Farhad Ravandi

    Published 2019
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  5. 5
    FLT3 mutated acute myeloid leukemia: 2021 treatment algorithm

    FLT3 mutated acute myeloid leukemia: 2021 treatment algorithm by Naval Daver, Sangeetha Venugopal, Farhad Ravandi

    Published 2021
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  6. 6
    Acute promyelocytic leukemia current treatment algorithms

    Acute promyelocytic leukemia current treatment algorithms by Musa Yılmaz, Hagop M. Kantarjian, Farhad Ravandi

    Published 2021
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  7. 7
    Maintenance therapy in acute myeloid leukemia: advances and controversies

    Maintenance therapy in acute myeloid leukemia: advances and controversies by Jayastu Senapati, Tapan M. Kadia, Farhad Ravandi

    Published 2023
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  8. 8
    Treatment of older adults with FLT3-mutated AML: Emerging paradigms and the role of frontline FLT3 inhibitors

    Treatment of older adults with FLT3-mutated AML: Emerging paradigms and the role of frontline FLT3 inhibitors by Nicholas J. Short, Daniel Nguyen, Farhad Ravandi

    Published 2023
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  9. 9
    Evaluating measurable residual disease in acute myeloid leukemia

    Evaluating measurable residual disease in acute myeloid leukemia by Farhad Ravandi, Roland B. Walter, Sylvie D. Freeman

    Published 2018
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  10. 10
    Monoclonal antibodies in acute lymphoblastic leukemia

    Monoclonal antibodies in acute lymphoblastic leukemia by Elias Jabbour, Susan O’Brien, Farhad Ravandi, Hagop M. Kantarjian

    Published 2015
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  11. 11
    FLT3 inhibitors in the treatment of acute myeloid leukemia

    FLT3 inhibitors in the treatment of acute myeloid leukemia by Naveen Pemmaraju, Hagop M. Kantarjian, Farhad Ravandi, Jorge E. Cortés

    Published 2011
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  12. 12
    Progress in the treatment of acute myeloid leukemia

    Progress in the treatment of acute myeloid leukemia by Farhad Ravandi, Alan K. Burnett, Edward Agura, Hagop M. Kantarjian

    Published 2007
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  13. 13
    Emerging treatment paradigms with FLT3 inhibitors in acute myeloid leukemia

    Emerging treatment paradigms with FLT3 inhibitors in acute myeloid leukemia by Nicholas J. Short, Hagop M. Kantarjian, Farhad Ravandi, Naval Daver

    Published 2019
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  14. 14
    The Search for Better Prognostic Models in Myelodysplastic Syndromes

    The Search for Better Prognostic Models in Myelodysplastic Syndromes by Fabio P S Santos, Hagop M. Kantarjian, Guillermo Garcia‐Manero, Farhad Ravandi

    Published 2010
    Get full text
    Revisão
    Save to List
    Saved in:
  15. 15
    Forodesine, an inhibitor of purine nucleoside phosphorylase, induces apoptosis in chronic lymphocytic leukemia cells

    Forodesine, an inhibitor of purine nucleoside phosphorylase, induces apoptosis in chronic lymphocytic leukemia cells by Kumudha Balakrishnan, Ramadevi Nimmanapalli, Farhad Ravandi, Michael J. Keating, Varsha Gandhi

    Published 2006
    Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    New drugs in acute myeloid leukemia

    New drugs in acute myeloid leukemia by Tapan M. Kadia, Farhad Ravandi, Jorge E. Cortés, Hagop M. Kantarjian

    Published 2016
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  17. 17
    The bruton tyrosine kinase inhibitor ibrutinib (<scp>PCI</scp>‐32765) blocks hairy cell leukaemia survival, proliferation and <scp>B</scp> cell receptor signalling: a new therapeutic approach

    The bruton tyrosine kinase inhibitor ibrutinib (<scp>PCI</scp>‐32765) blocks hairy cell leukaemia survival, proliferation and <scp>B</scp> cell receptor signalling: a new therapeut... by Mariela Sivina, Robert J. Kreitman, Evgeny Arons, Farhad Ravandi, Jan A. Burger

    Published 2014
    Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    The Role of JAK Pathway Dysregulation in the Pathogenesis and Treatment of Acute Myeloid Leukemia

    The Role of JAK Pathway Dysregulation in the Pathogenesis and Treatment of Acute Myeloid Leukemia by Hun Ju Lee, Naval Daver, Hagop M. Kantarjian, Srđan Verstovšek, Farhad Ravandi

    Published 2012
    Get full text
    Revisão
    Save to List
    Saved in:
  19. 19
    Evolving therapy of adult acute lymphoblastic leukemia: state-of-the-art treatment and future directions

    Evolving therapy of adult acute lymphoblastic leukemia: state-of-the-art treatment and future directions by Bachar Samra, Elias Jabbour, Farhad Ravandi, Hagop M. Kantarjian, Nicholas J. Short

    Published 2020
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  20. 20
    Prognostic and therapeutic implications of measurable residual disease in acute myeloid leukemia

    Prognostic and therapeutic implications of measurable residual disease in acute myeloid leukemia by Marisa J.L. Aitken, Farhad Ravandi, Keyur P. Patel, Nicholas J. Short

    Published 2021
    Get full text Get full text
    Revisão
    Save to List
    Saved in:

Search Tools: